David Jesse Moody - Jan 17, 2025 Form 4 Insider Report for Danimer Scientific, Inc. (DNMR)

Role
Director
Signature
/s/ Stephen A. Martin, attorney-in-fact
Stock symbol
DNMR
Transactions as of
Jan 17, 2025
Transactions value $
$0
Form type
4
Date filed
1/21/2025, 04:30 PM
Previous filing
Jul 22, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNMR Class A Common Stock Options Exercise $0 +646 $0.00 646 Jan 17, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNMR Restricted Stock Units Options Exercise $0 -646 -100% $0.00 0 Jan 17, 2025 Common Stock 646 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Danimer Scientific Class A common stock.
F2 On November 12, 2024, the common stock of Danimer Scientific, Inc. reverse split 1 for 40.
F3 Comprised of an award of restricted stock units (RSU) granted as director compensation under the Danimer Scientific, Inc. 2020 Long-Term Incentive Plan (the "Plan") with each RSU representing the right to receive one share of Danimer Scientific Class A Common Stock. All of these RSU's will vest and become non-forfeitable on January 17, 2025 subject to recipient's continued service as a director of the Company.